A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release

FASEB Journal

Volumn 21, Issue 2, 2007, Pages 577-585

  Rayment, Sarah J ^a   Ralevic, Vera ^a   Barrett, David A ^b   Cordell, Rebecca ^b   Alexander, Stephen P H ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adenine nucleotides; Adenosine A2A receptor; Purine release; RT PCR

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR BLOCKING AGENT; PURINE P2 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; TRITIUM;

AMINO ACID METABOLISM; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ENZYME INHIBITION; EXTRACELLULAR SPACE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; SWINE; UPREGULATION; VASODILATATION;

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; MALE; MOLECULAR SEQUENCE DATA; PYRIDOXAL PHOSPHATE; PYRIMIDINES; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SWINE; TRIAZOLES; VASODILATION; VASODILATOR AGENTS;

SUS;

EID: 33846819951     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7050com     Document Type: Article

References (47)

1. Boarder, M. R., Hourani, S. M. O. (1998) The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends. Pharmacol. Sci. 19, 99-107
2. 2 receptor subtypes in the cardiovascular system. Biochem. J. 336, 513-23
3. Ralevic, V., Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-92
4. Von Kugelgen, I. (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 110, 415-32
5. Beigi, R., Kobatake, E., Aizawa, M., Dubyak, G. R. (1999) Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am. J. Physiol. Cell. Physiol. 276, C267-C278
6. Sprague, R. S., Ellsworth, M. L., Stephenson, A. H., Kleinhenz, M. E., Lonigro, A. J. (1998) Deformation-induced ATP release from red blood cells requires CFTR activity. Am. J. Physiol. Heart Circ. Physiol. 44, H1726-H1732
7. Yegutkin, G., Bodin, P., Burnstock, G. (2000) Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5′-nucleotidase along with endogenous ATP from vascular endothelial cells. Br. J. Pharmacol. 129, 921-926
8. Shinozuka, K., Hashimoto, M., Masumura, S., Bjur, R. A., Westfall, D. P., Hattori, K. (1994) In vitro studies of release of adenine nucleotides and adenosine from rat vascular endothelium in response to α1-adrenoceptor stimulation. Br. J. Pharmacol. 113, 1203-1208
9. Alexander, S. P. H., Mathie, A., Peters, J. A. (2006) Guide to Receptors and Channels, 2nd Edition. Br. J. Pharmacol. 147, S1-S183
10. 14 receptor) adds diversity to the P2Y receptor family. Trends. Pharmacol. Sci. 24, 52-55
11. Communi, D., Govaerts, C., Parmentier, M., Boeynaems, J. M. (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J. Biol. Chem. 272, 31969-31973
12. 11 Receptors. Mol. Pharmacol. 60, 1375-1382
13. 1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett. 403, 26-30
14. 1 receptor. Mol. Pharmacol. 65, 426-436
15. 13 receptor. Mol. Pharmacol. 64, 104-112
16. Bodor, E. T., Waldo, G. L., Hooks, S. B., Corbitt, J., Boyer, J. L., Harden, T. K. (2003) Purification and functional reconstitution of the human P2Y12 receptor. Mol. Pharmacol. 64, 1210-1216
17. Corr, L., Burnstock, G. (1994) Analysis of P2-purinoceptor subtypes on the smooth muscle and endothelium of rabbit coronary artery. J. Cardiovasc. Pharmacol. 23, 709-715
18. Keef, K. D., Pasco, J. S., Eckman, D. M. (1992) Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium. J. Pharmacol. Exp. Ther. 260, 592-600
19. Simonsen, U., García-Sacristán, A., Prieto, D. (1997) Involvement of ATP in the non-adrenergic non-cholinergic inhibitory neurotransmission of lamb isolated coronary small arteries. Br. J. Pharmacol. 120, 411-420
20. Saetrum, O. O., Edvinsson, L. (1997) Mechanical properties and effects of sympathetic co-transmitters on human coronary arteries and veins. Basic. Res. Cardiol. 92, 168-180
21. Blaylock, N. A., Wilson, V. G. (1991) Preliminary evidence for noradrenaline and ATP as neurotransmitters in the porcine isolated palmar common digital artery. J. Neural. Transm. 34, 99-105
22. Ting, N., Thambyraja, A., Sugden, D., Scalbert, E., Delagrange, P., Wilson, V. G. (2000) Pharmacological studies on the inhibitory action of melatonin and putative melatonin analogues on porcine vascular smooth muscle. Naunyn-Schmiedeberg's. Arch. Pharmacol. 361, 327-333
23. Schrier, S. M., Florea, B. I., Mulder, G. J., Nagelkerke, J. F., IJzerman, A. P. (2002) Apoptosis induced by extracellular ATP in the mouse neuroblastoma cell line N1E-115: studies on involvement of P2 receptors and adenosine. Biochem. Pharmacol. 63, 1119-1126
24. 2A receptors in rat brain. Eur. J. Pharmacol. 411, 205-210
25. Cadogan, A.-K., Alexander, S. P. H., Boyd, E. A., Kendall, D. A. (1997) Influence of cannabinoids on electrically-evoked dopamine release and cyclic AMP generation in the rat striatum. J. Neurochem. 69, 1131-1137
26. Chenna, R., Sugawara, H., Koike, T., Lopez, R., Gibson, T. J., Higgins, D. G., Thompson, J. D. (2003) Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31, 3497-3500
27. 2A receptor in coronary arteriolar dilation to adenosine. Drug. Dev. Res. 52, 350-356
28. 2A receptors in human and porcine cardiovascular tissues. J. Pharmacol. Exp. Ther. 286, 1051-1057
29. 2a adenosine receptor antagonist. J. Pharmacol. Exp. Ther. 276, 398-404
30. Schrier, S. M., van Tilburg, E. W., van der Meulen, H., IJzerman, A. P., Mulder, G. J., Nagelkerke, J. F. (2001) Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. Biochem. Pharmacol. 61, 417-425
31. 1 receptors. J. Med. Chem. 41, 183-190
32. 1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J. Med. Chem. 41, 1456-1466
33. 2A-receptor antagonist ZM241385. J. Cardiovasc. Pharmacol. 35, 322-325
34. 2A adenosine receptors in particulate and slice preparations from porcine striatum. Br. J. Pharmacol. 128, 182P
35. Westfall, T. D., Kennedy, C., Sneddon, P. (1996) Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156. Br. J. Pharmacol. 117, 867-872
36. Crack, B. E., Pollard, C. E., Beukers, M. W., Roberts, S. M., Hunt, S. F., Ingall, A. H., McKechnie, K. C. W., Ijzerman, T. P., Leff, P. (1995) Pharmacological analysis and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol. 114, 475-481
37. Picher, M., Burch, L. H., Hirsh, A. J., Spychala, J., Boucher, R. C. (2003) Ecto 5́-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J. Biol. Chem. 278, 13468-13479
38. Ohkubo, S., Matsuoka, I., Kimura, J., Nakanishi, H. (1998) Inhibition of ATP-induced cAMP formation by 5́-p-fluorosulfonylbenzoyladenosine in NG108-15 cells. Naunyn-Schmiedeberg's. Arch. Pharmacol. 358, 153-159
39. Sevigny, J., Levesque, F. P., Grondin, G., Beaudoin, A. R. (1997) Purification of the blood vessel ATP diphosphohydrolase, identification and localisation by immunological techniques. Biochim. Biophys. Acta-Gen. Subj. 1334, 73-88
40. Zimmermann, H. (2001) Ectonucleotidases: Some recent developments and a note on nomenclature. Drug. Dev. Res. 52, 44-56
41. Sperlagh, B., Szabo, G., Erdelyi, F., Baranyi, M., Vizi, E. S. (2003) Homo- and heteroexchange of adenine nucleotides and nucleosides in rat hippocampal slices by the nucleoside transport system. Br. J. Pharmacol. 139, 623-633
42. Cristalli, G., Costanzi, S., Lambertucci, C., Lupidi, G., Vittori, S., Volpini, R., Camaioni, E. (2001) Adenosine deaminase: functional implications and different classes of inhibitors. Med. Res. Rev. 21, 105-128
43. Anwar, Z., Albert, J. L., Gubby, S. E., Boyle, J. P., Roberts, J. A., Webb, T. E., Boarder, M. R. (1999) Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells. Br. J. Pharmacol. 128, 465-471
44. King, B. F., Wildman, S. S., Townsend-Nicholson, A., Burnstock, G. (1998) Antagonism of an adenosine/ATP receptor in follicular Xenopus oocytes. J. Pharmacol. Exp. Ther. 285, 1005-1011
45. 1 and P2 receptor antagonists on β,γ-methyleneATP- and CGS21680-induced cyclic AMP generation in NG108-15 cells. Br. J. Pharmacol. 129, 291-298
46. Todorov, L. D., Bjur, R. A., Westfall, D. P. (1994) Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves. Biochem. Biophys. Res. Commun. 268, 985-989
47. 3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors. Naunyn-Schmiedeberg's. Arch. Pharmacol. 346, 187-196